You are here
NIH-Wide Strategic Plan
On this page
In order to advance its mission and fulfill requirements of the 21st Century Cures Act, NIH will update its Strategic Plan every 5 years. The most recent iteration, the NIH-Wide Strategic Plan for Fiscal Years 2021–2025, is an update on the previous plan for fiscal years 2016–2020.
The Strategic Plan outlines NIH’s vision for biomedical research direction, capacity, and stewardship, by articulating the highest priorities of NIH over the next 5 years. In addition, it provides illustrative examples of accomplishments under the last plan and new initiatives under this one. The Strategic Plan was developed through collaboration between leadership and staff across NIH and key stakeholders, including the research community, professional societies, advocacy groups, and the public.
The NIH-Wide Strategic Plan is designed to complement and harmonize Institute and Center (IC) strategic plans across NIH, which address their individual missions
NIH designed a Framework to inform development of the Strategic Plan. This Framework identifies areas of opportunity that apply across biomedical research and unifying principles to guide NIH in supporting the biomedical research enterprise. The Framework includes three key Objectives that outline NIH’s priorities as aligned with the agency’s goals. Across all of these priorities, NIH emphasizes several Cross-Cutting Themes—approaches that are common to all Objectives of the Strategic Plan.
In September 2019, NIH began updating the NIH-Wide Strategic Plan to cover fiscal years 2021–2025, adopting a process that was meant to be transparent, focused on science and good stewardship of research, guided by evidence, and informed by NIH’s many stakeholders.
The four phases of the strategic planning process included:
This page last reviewed on July 30, 2021